Monsanto Licenses Cellectis Technology for Genome Modifications | GenomeWeb

NEW YORK (GenomeWeb News) – The bio-agricultural company Monsanto will use Cellectis' meganuclease genomic engineering technology under a new license agreement, Cellectis said today.

The Cellectis technology involves using "molecular scissors" that can locate a single site in the genome of a plant cell, allowing a range of precise genome modifications, such as gene stacking, gene knock-out, and modulation of gene function.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.